首页> 外文期刊>Journal of tissue engineering and regenerative medicine >A double chamber rotating bioreactor for enhanced tubular tissue generation from human mesenchymal stem cells: a promising tool for vascular tissue regeneration
【24h】

A double chamber rotating bioreactor for enhanced tubular tissue generation from human mesenchymal stem cells: a promising tool for vascular tissue regeneration

机译:双腔旋转生物反应器,用于增强人间充质干细胞的管状组织产生:血管组织再生的一个有希望的工具

获取原文
获取原文并翻译 | 示例
           

摘要

Cardiovascular diseases represent a major global health burden, with high rates of mortality and morbidity. Autologous grafts are commonly used to replace damaged or failing blood vessels; however, such approaches are hampered by the scarcity of suitable graft tissue, donor site morbidity and poor long-term stability. Tissue engineering has been investigated as a means by which exogenous vessel grafts can be produced, with varying levels of success to date, a result of mismatched mechanical properties of these vessel substitutes and inadequate ex vivo vessel tissue genesis. In this work, we describe the development of a novel multifunctional dual-phase (air/aqueous) bioreactor, designed to both rotate and perfuse small-diameter tubular scaffolds and encourage enhanced tissue genesis throughout such scaffolds. Within this novel dynamic culture system, an elastomeric nanofibrous, microporous composite tubular scaffold, composed of poly(caprolactone) and acrylated poly(lactide-co-trimethylene-carbonate) and with mechanical properties approaching those of native vessels, was seeded with human mesenchymal stem cells (hMSCs) and cultured for up to 14 days in inductive (smooth muscle) media. This scaffold/bioreactor combination provided a dynamic culture environment that enhanced (compared with static controls) scaffold colonization, cell growth, extracellular matrix deposition and in situ differentiation of the hMSCs into mature smooth muscle cells, representing a concrete step towards our goal of creating a mature ex vivo vascular tissue for implantation. Copyright (C) 2016 John Wiley & Sons, Ltd.
机译:心血管疾病代表着一个主要的全球健康负担,具有高的死亡率和发病率。自体移植物通常用于替换损坏或失败的血管;然而,这种方法受到合适的接枝组织,供体部位发病率和差的长期稳定性的稀缺而受到阻碍。已经研究了组织工程作为可以制造外源容器移植物的方法,其迄今为止的成功水平不同,因此这些血管的机械性能不匹配,并且不足的离体血管组织创世纪。在这项工作中,我们描述了一种新型多功能双相(空气/含水)生物反应器的开发,设计成旋转和灌注小直径管状支架,并促进在整个这样的支架中增强的组织创世纪。在该新型动态培养系统中,由聚(己内酯)和丙烯酸酯(丙交酯 - 共聚甲基 - 碳酸酯)组成的弹性型纳米纤维,微孔复合管支架和接近天然血管的机械性能,与人的间充质茎接种细胞(HMSCs)并在电感(平滑肌)培养基中培养最多14天。这种支架/生物反应器组合提供了一种动态培养环境,可增强(与静态控制相比)支架定植,细胞生长,细胞外基质沉积和HMSCs的原位分化为成熟平滑肌细胞,代表我们创建一个具体步骤成熟的前体内血管组织植入。版权所有(c)2016 John Wiley&Sons,Ltd。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号